172 related articles for article (PubMed ID: 10570698)
1. Management of stimulant medications in children with attention-deficit/hyperactivity disorder.
Adesman AR; Morgan AM
Pediatr Clin North Am; 1999 Oct; 46(5):945-63, vii-viii. PubMed ID: 10570698
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association.
Goldman LS; Genel M; Bezman RJ; Slanetz PJ
JAMA; 1998 Apr; 279(14):1100-7. PubMed ID: 9546570
[TBL] [Abstract][Full Text] [Related]
3. Stimulant therapy in children with attention-deficit/hyperactivity disorder and concomitant long QT syndrome: A safe combination?
Rohatgi RK; Bos JM; Ackerman MJ
Heart Rhythm; 2015 Aug; 12(8):1807-12. PubMed ID: 25956966
[TBL] [Abstract][Full Text] [Related]
4. Stimulant medication for the child with attention-deficit/hyperactivity disorder.
Bennett FC; Brown RT; Craver J; Anderson D
Pediatr Clin North Am; 1999 Oct; 46(5):929-44, vii. PubMed ID: 10570697
[TBL] [Abstract][Full Text] [Related]
5. ADHD stimulants and their effect on height in children.
Goldman RD
Can Fam Physician; 2010 Feb; 56(2):145-6. PubMed ID: 20154245
[TBL] [Abstract][Full Text] [Related]
6. Factors influencing parental decision making about stimulant treatment for attention-deficit/hyperactivity disorder.
Ahmed R; McCaffery KJ; Aslani P
J Child Adolesc Psychopharmacol; 2013 Apr; 23(3):163-78. PubMed ID: 23560602
[TBL] [Abstract][Full Text] [Related]
7. Is adjunctive pharmacotherapy in attention-deficit/hyperactivity disorder cost-effective in Canada: a cost-effectiveness assessment of guanfacine extended-release as an adjunctive therapy to a long-acting stimulant for the treatment of ADHD.
Lachaine J; Sikirica V; Mathurin K
BMC Psychiatry; 2016 Jan; 16():11. PubMed ID: 26774811
[TBL] [Abstract][Full Text] [Related]
8. A comparison of ritalin and adderall: efficacy and time-course in children with attention-deficit/hyperactivity disorder.
Pelham WE; Aronoff HR; Midlam JK; Shapiro CJ; Gnagy EM; Chronis AM; Onyango AN; Forehand G; Nguyen A; Waxmonsky J
Pediatrics; 1999 Apr; 103(4):e43. PubMed ID: 10103335
[TBL] [Abstract][Full Text] [Related]
9. Long-term safety of stimulant medications used to treat children with ADHD.
Lerner M; Wigal T
Pediatr Ann; 2008 Jan; 37(1):37-45. PubMed ID: 18240852
[No Abstract] [Full Text] [Related]
10. A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder.
Stein MA; Sarampote CS; Waldman ID; Robb AS; Conlon C; Pearl PL; Black DO; Seymour KE; Newcorn JH
Pediatrics; 2003 Nov; 112(5):e404. PubMed ID: 14595084
[TBL] [Abstract][Full Text] [Related]
11. Persistence of stimulants in children and adolescents with attention-deficit/hyperactivity disorder.
Palli SR; Kamble PS; Chen H; Aparasu RR
J Child Adolesc Psychopharmacol; 2012 Apr; 22(2):139-48. PubMed ID: 22364400
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular risk of stimulant treatment in pediatric attention-deficit/hyperactivity disorder: update and clinical recommendations.
Hammerness PG; Perrin JM; Shelley-Abrahamson R; Wilens TE
J Am Acad Child Adolesc Psychiatry; 2011 Oct; 50(10):978-90. PubMed ID: 21961773
[TBL] [Abstract][Full Text] [Related]
13. The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: A systematic review with network meta-analyses of randomised trials.
Catalá-López F; Hutton B; Núñez-Beltrán A; Page MJ; Ridao M; Macías Saint-Gerons D; Catalá MA; Tabarés-Seisdedos R; Moher D
PLoS One; 2017; 12(7):e0180355. PubMed ID: 28700715
[TBL] [Abstract][Full Text] [Related]
14. Period prevalence of concomitant psychotropic medication usage among children and adolescents with attention-deficit/hyperactivity disorder during 2009.
Betts KA; Sikirica V; Hodgkins P; Zhou Z; Xie J; DeLeon A; Erder MH; Wu EQ
J Child Adolesc Psychopharmacol; 2014 Jun; 24(5):260-8. PubMed ID: 24839998
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness and Side Effect Profile of Stimulant Medication for the Treatment of Attention-Deficit/Hyperactivity Disorder in Youth with Epilepsy.
Kral MC; Lally MD; Boan AD
J Child Adolesc Psychopharmacol; 2017 Oct; 27(8):735-740. PubMed ID: 28383998
[TBL] [Abstract][Full Text] [Related]
16. Pharmacotherapy for incident attention-deficit/hyperactivity disorder: practice patterns and quality metrics.
Bussing R; Narwaney KJ; Winterstein AG; Newton DA; DeBar L; Boscarino JA; Toh S; Pawloski P; Nordin JD; Herrinton LJ; Mason D; Daley MF
Curr Med Res Opin; 2014 Aug; 30(8):1687-99. PubMed ID: 24635013
[TBL] [Abstract][Full Text] [Related]
17. Psychotropic medication use in a population of children who have attention-deficit/hyperactivity disorder.
Guevara J; Lozano P; Wickizer T; Mell L; Gephart H
Pediatrics; 2002 May; 109(5):733-9. PubMed ID: 11986429
[TBL] [Abstract][Full Text] [Related]
18. Advances and considerations in attention-deficit/hyperactivity disorder pharmacotherapy.
Mohammadi M; Akhondzadeh S
Acta Med Iran; 2011; 49(8):487-98. PubMed ID: 22009816
[TBL] [Abstract][Full Text] [Related]
19. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P
Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
[TBL] [Abstract][Full Text] [Related]
20. Long-term use of stimulants in children with attention deficit hyperactivity disorder: safety, efficacy, and long-term outcome.
Hechtman L; Greenfield B
Paediatr Drugs; 2003; 5(12):787-94. PubMed ID: 14658920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
